Corvus Pharmaceuticals (CRVS) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Corvus Pharmaceuticals (CRVS) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Corvus Pharmaceuticals

· CRVS

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

989.262 M

-2.04%

General

Market Cap: $989.26M
Enterprise Value: $950.54M
Shares Outstanding: 84,090,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -22.62%
ROE: -36.15%
ROIC: -25.20%
Current Ratio: 16.16
Debt-to-Equity: 0.00
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 4.30
EV/EBITDA: -18.46

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $56.94M
Operating Income: -$56.96M
Net Profit: -$54.13M

Balance Sheet

Cash and Equivalents: $18.91M
Working Capital: $207.29M
Total Assets: $239.27M
Net Debt: -$18.18M
Total Liabilities: $13.95M
Total Equity: $225.33M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$44.53M
Cash Flow from Investing: -$142.55M
Cash Flow from Financing: $191.29M
Free Cash Flow: -$45.23M
Capital Expenditures: $698K